Popular on EntSun
- Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates - 412
- Stitt Entertainment Names Tristan Xavier Lead Stylist - 345
- ChargeOn Announces Conversational Payment Management Solution - 341
- Mecca to Mars: Earth's Escape? - 250
- Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A! - 230
- Rehearsals Begin on 'The Call List' by Brian James Polak - 217
- Free JavaScript Charting Library ProEssentialsJS Permits Commercial Use. Highcharts, SciChart and LightningChart Free Tiers Do Not - 215
- Volant Announces Major Partnership with the STEM Racing Canada Program to CHAMPION YOUTH ENGINEERING - 202
- Big Panic Records Announces "African Sunshine" by Believe, Shirley Jones & Omasta - 198
- Yalil Guerra's "Clave" to Receive World Premiere in New Symphonic Version at The Soraya - 182
Similar on EntSun
- Infinity Infusion Solutions Named Finalist for D Magazine's D CEO 2026 Excellence in Healthcare Awards
- Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)
- International Society of Medical AI Convenes Global Faculty in Florence for ISMAI 2026
- Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
- European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- Mandeville Pests May Pose Serious Health Risks for Your Family
- Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
Parkinson's Disease Study from The Michael J. Fox Foundation
EntSun News/10757537
First Choice Neurology to participate in Parkinson's disease study from The Michael J. Fox Foundation.
MIAMI - Nov. 6, 2018 - EntSun -- A new online Parkinson's disease study is available from The Michael J. Fox Foundation by Fox Insight. Fox Insight is an online clinical study where people with Parkinson's disease and their loved ones share information that could transform the search for better treatments. By joining Fox Insight you can help shape the future of Parkinson's research — but it's going to take all of us, working together.
No one understands Parkinson's better than those living with it every day. By working together, we can help shape the future of research. Fox Insight easily collects self-reported data about health experiences from those with and without Parkinson's in a number of ways. Eligible individuals can help researchers gain a holistic picture of the disease by participating in a genetic sub-study.
More on EntSun News
Fox Insight Parkinson's Disease Study
Fox Insight is an online clinical study that empowers patients, control volunteers and researchers to work together toward Parkinson's disease breakthroughs.
The flexible study design allows participants to contribute data in a variety of ways:
Fox Insight Parkinson's Disease Participants
Fox Insight participants complete virtual study visits every 3 months, and data they contribute enables high-impact scientific collaboration toward patient-relevant outcomes.
Through online study visits (45 to 60 minutes), participants fill out a series of questionnaires to provide critical insights on:
Additional research opportunities such as add-on questionnaires and sub-studies will be integrated into the Fox Insight platform.
More on EntSun News
Fox Insight is currently enrolling anyone who:
Over 22,000 participants are already contributing information about their experience with Parkinson's disease (PD).
By participating in genetics research, Parkinson's disease patients can help speed the development process toward personalized therapies that may slow or stop the disease. For more information about the study, visit First Choice Neurology blog at https://www.fcneurology.net/parkinsons-disease-study-from-the-michael-j-fox-foundation/
No one understands Parkinson's better than those living with it every day. By working together, we can help shape the future of research. Fox Insight easily collects self-reported data about health experiences from those with and without Parkinson's in a number of ways. Eligible individuals can help researchers gain a holistic picture of the disease by participating in a genetic sub-study.
More on EntSun News
- Can Government Operate Better Through Innovation?
- Michael H. Kaplan Advocates for Seriously Injured Colorado Workers Who Need In-Home Care
- Kara Fleege, Mrs. Orlando 2023, Walks New York Fashion Week Runway for Revolution A
- Angel Taylor: A New Season, A Powerful Message of Faith
- Wig Floater Introduces a Convenient Magnetic Hanging Solution for Wig Storage
Fox Insight Parkinson's Disease Study
Fox Insight is an online clinical study that empowers patients, control volunteers and researchers to work together toward Parkinson's disease breakthroughs.
The flexible study design allows participants to contribute data in a variety of ways:
- Routine health-related surveys
- Optional, add-on surveys and sub-studies including genetic testing
- Future remote data collection (e.g. wearables, keyboard tapping, biologic samples)
Fox Insight Parkinson's Disease Participants
Fox Insight participants complete virtual study visits every 3 months, and data they contribute enables high-impact scientific collaboration toward patient-relevant outcomes.
Through online study visits (45 to 60 minutes), participants fill out a series of questionnaires to provide critical insights on:
- Symptoms
- Physical function
- Medications
- Quality of life
- Unmet Needs
- Healthcare preferences
Additional research opportunities such as add-on questionnaires and sub-studies will be integrated into the Fox Insight platform.
More on EntSun News
- Joe & Jada Bring Live Podcast And Performance To Baltimore's Waterfront At Pier Six Pavilion
- R&B Singer-Songwriter Nyasia Chane'l Set to Perform at Newark's 2026 Halsey Festival
- Horror Haven Film Expo Brings Two Days of Independent Horror to Evansville
- Delirious TV Goes Live From Las Vegas And Streams Around The World
- Infinity Infusion Solutions Named Finalist for D Magazine's D CEO 2026 Excellence in Healthcare Awards
Fox Insight is currently enrolling anyone who:
- Is 18 years old or older
- Has a Parkinson's diagnosis
- Is able to complete health questionnaires in English
- Has access to the internet
Over 22,000 participants are already contributing information about their experience with Parkinson's disease (PD).
By participating in genetics research, Parkinson's disease patients can help speed the development process toward personalized therapies that may slow or stop the disease. For more information about the study, visit First Choice Neurology blog at https://www.fcneurology.net/parkinsons-disease-study-from-the-michael-j-fox-foundation/
Source: First Choice Neurology
0 Comments
Latest on EntSun News
- International Society of Medical AI Convenes Global Faculty in Florence for ISMAI 2026
- Boston Industrial Solutions Introduces Personalized Printing Training
- Century Fasteners de Mexico Exhibiting at the 2026 Automotive & Aerospace Nearshoring Summit
- Lovecraft In Florida Blu-Ray Release
- Retell AI White Label Platform for Agencies Launched by VoiceAIWrapper, With Branded Client Portals and No Per-Minute Markup
- Events by Dubsdread Celebrates Cultural Traditions with New Guide on Faith-Based Wedding Traditions Across Cultures
- FOCUS Names Mark Phillips Senior Vice President of Business Development
- Get The Led Out Bring an Outstanding Tribute to Led Zeppelin to the Weinberg Center
- Cemetery Cinema is now available for Syndication!!!!
- Notaron Expands Online Notarization Access Following Wisconsin Approval
- Michelle Carey Releases Maryland Political Thriller, The Crofton Triangle
- Before Drake Was Drake, Detroit-Raised KayeDinero Was Already Watching Aubrey Graham
- Mountaineers Roll Out All-In-One Social Hub and Exclusive Content Vault on Brian Walton's Site
- Wings Air Helicopters Selected to Support VIP Transportation for Resorts World in New York
- Comedian Bubba Dub Brings Live Comedy Special to Florida Memorial University on September 26
- Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Houston This October
- Before Drake Was Drake, KayeDinero Was Already Watching Aubrey Graham
- The Social Capital Revolution Comes to Phoenix!
- Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
- FBI/DoW plot uncovered to hurt Trump/Vance through encouraged "widespread" cybersecurity breaches and racketeering theft of $80m in USDA payments
